Discover

DGX
Quest Diagnostics Incorporated
216.02
300 x undefined
100 x undefined
bid
ask
+
4.07
1.92%
200 @ 07:01 AM
216.10 +0.08 (0.04%)
Ytd24.49%
1y20.46%
211.40
day range
216.87
164.65
52 week range
216.87
Open213.67Prev Close211.95Low211.40High216.87Mkt Cap23.91B
Vol679.81KAvg Vol914.20KEPS9.05P/E23.87Forward P/E18.51
Beta0.59Short Ratio4.17Inst. Own97.85%Dividend3.44Div Yield1.62
Ex Div Date07-08Earning07-2350-d Avg196.86200-d Avg190.561yr Est223.44

DGX News

DGX's Stock Rises on Haystack MRD Test's Approval From NYSDOH
zacks.com
DGX's Stock Rises on Haystack MRD Test's Approval From NYSDOH

Quest Diagnostics gains NYSDOH approval for Haystack MRD, expanding the cancer test to all 50 states

benzinga.com
Quest Diagnostics Receives New York's Department of Health's Clinical Laboratory Evaluation Program

Quest Diagnostics® (NYSE:DGX), a leading provider of diagnostic information services, today announce

benzinga.com
UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $220

UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the p

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings
benzinga.com
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

Quest Diagnostics (DGX) reported strong Q1 earnings, beating expectations and raising guidance. Anal

benzinga.com
Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $229

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the

benzinga.com
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $230

Barclays analyst Luke Sergott maintains Quest Diagnostics (NYSE:DGX) with a Overweight and raises

benzinga.com
Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $225

Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and

Quest Diagnostics Gains Steam With Partnerships, Lifts Outlook
benzinga.com
Quest Diagnostics Gains Steam With Partnerships, Lifts Outlook

Quest Diagnostics Q1 revenue grew 9.2% as organic volume surged. Discover how new partnerships and A

Valmont Industries Posts Upbeat Q1 Results, Joins UnitedHealth Group, Quest Diagnostics And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Valmont Industries Posts Upbeat Q1 Results, Joins UnitedHealth Group, Quest Diagnostics And Other Bi

Quest Diagnostics Q1 2026 Earnings Call: Complete Transcript
benzinga.com
Quest Diagnostics Q1 2026 Earnings Call: Complete Transcript

Earnings Scheduled For April 21, 2026
benzinga.com
Earnings Scheduled For April 21, 2026

benzinga.com
Quest Diagnostics Raises FY2026 GAAP EPS Guidance from $9.45-$9.65 to $9.58-$9.78 vs $9.43 Est.

Quest Diagnostics (NYSE:DGX) raises FY2026 GAAP EPS guidance from $9.45-$9.65 to $9.58-$9.78 vs $9.4

benzinga.com
Quest Diagnostics Raises FY2026 Adj EPS Guidance from $10.50-$10.70 to $10.63-$10.83 vs $10.55 Est;

Quest Diagnostics (NYSE:DGX) raises FY2026 Adj EPS guidance from $10.50-$10.70 to $10.63-$10.83 vs $

benzinga.com
Quest Diagnostics Q1 Adj. EPS $2.50 Beats $2.35 Estimate, Sales $2.895B Beat $2.827B Estimate.

Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $2.50 per share which beat the analyst c

benzinga.com
Evercore ISI Group Maintains In-Line on Quest Diagnostics, Lowers Price Target to $210

Evercore ISI Group analyst Elizabeth Anderson maintains Quest Diagnostics (NYSE:DGX) with a In-Li

benzinga.com
Quest Diagnostics Launches Gemini-Powered Quest AI Companion To Analyze Up To 5-Years Of Lab Results

New feature based on Google's Gemini seamlessly analyzes up to five years of personal lab data t

benzinga.com
Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $235

Mizuho analyst Ann Hynes maintains Quest Diagnostics (NYSE:DGX) with a Outperform and raises the

Forecasting The Future: 6 Analyst Projections For Quest Diagnostics
benzinga.com
Forecasting The Future: 6 Analyst Projections For Quest Diagnostics

benzinga.com
Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $220

Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and

benzinga.com
UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $210

UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the p

benzinga.com
Evercore ISI Group Maintains In-Line on Quest Diagnostics, Raises Price Target to $220

Evercore ISI Group analyst Elizabeth Anderson maintains Quest Diagnostics (NYSE:DGX) with a In-Li

benzinga.com
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $225

Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Overweight and rai

Walmart To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Walmart To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Wednesday

benzinga.com
Jefferies Maintains Buy on Quest Diagnostics, Raises Price Target to $220

Jefferies analyst Tycho Peterson maintains Quest Diagnostics (NYSE:DGX) with a Buy and raises the

Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike
benzinga.com
Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike

Quest Diagnostics (NYSE: DGX) reported Q4 earnings of $2.42 per share, beating expectations. Sales w

Datadog, Spotify, Marriott, Ferrari And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Datadog, Spotify, Marriott, Ferrari And Other Big Stocks Moving Higher On Tuesday

benzinga.com
Quest Diagnostics Sees FY2026 GAAP EPS $9.45-$9.65 vs $9.30 Est

Guidance for Full Year 2026The company estimates its full year 2026 guidance in the table below. The

benzinga.com
Quest Diagnostics Sees FY2026 Adj EPS $10.50-$10.70 vs $10.43 Est; Sees Sales $11.700B-$11.820B vs $

Guidance for Full Year 2026The company estimates its full year 2026 guidance in the table below. The

Earnings Breakdown: Quest Diagnostics Q4
benzinga.com
Earnings Breakdown: Quest Diagnostics Q4

benzinga.com
Quest Diagnostics Q4 Adj. EPS $2.42 Beats $2.36 Estimate, Sales $2.806B Beat $2.754B Estimate

Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $2.42 per share which beat the analyst c

benzinga.com
Quest Diagnostics Authorized 7.5% Increase In Its Quarterly Cash Dividend To $0.86/Share From $0.80/

The increase is effective with the dividend payable on April 20, 2026 to shareholders of record of Q

Earnings Scheduled For February 10, 2026
benzinga.com
Earnings Scheduled For February 10, 2026

Insights into Quest Diagnostics's Upcoming Earnings
benzinga.com
Insights into Quest Diagnostics's Upcoming Earnings

benzinga.com
Quest Diagnostics Launches Blood Test Using Advanced Flow Cytometry Methods To Assess Measurable Res

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to sup

How Do Investors Really Feel About Quest Diagnostics Inc?
benzinga.com
How Do Investors Really Feel About Quest Diagnostics Inc?

Looking Into Quest Diagnostics Inc's Recent Short Interest
benzinga.com
Looking Into Quest Diagnostics Inc's Recent Short Interest

benzinga.com
Octave Bioscience Enters Strategic Collaboration With Quest Diagnostics To Make The Octave MS Diseas

Collaboration enables patients to access the Octave MSDA test at Quest's approximately 7,000 pat

Gold Sinks 5% On Worst Day In 5 Years, Dow Jones Hits Record Highs: What's Moving Markets Tuesday?
benzinga.com
Gold Sinks 5% On Worst Day In 5 Years, Dow Jones Hits Record Highs: What's Moving Markets Tuesday?

Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this yea

benzinga.com
Earnings Scheduled For October 21, 2025

benzinga.com
Quest Diagnostics' Athena Diagnostics Announces New Laboratory Test Service Intended To Provide Insi

New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic c

benzinga.com
Athena Diagnostics Launches New Genetic Test For Ataxia Using PacBio's PureTarget Sequencing Technol

New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic c

Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday?
benzinga.com
Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday?

It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of

benzinga.com
Earnings Scheduled For July 22, 2025

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
benzinga.com
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
benzinga.com
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; f

Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stoc

benzinga.com
Earnings Scheduled For April 22, 2025

benzinga.com
Quest Diagnostics Acquires Select Assets Of Fresenius's Spectra Laboratories For Dialysis Testing Se

Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius M

IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday
benzinga.com
IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big St

benzinga.com
Earnings Scheduled For January 30, 2025